During embryogenesis the hematopoietic system develops through distinct waves that 15 generate progenitors with increasing lineage potential, ultimately producing 16 haematopoietic stem cells (HSCs). In vitro differentiation of human pluripotent stem cells 17 (hPSCs) follows the early steps of haematopoietic development but the production of 18
Introduction 30
Human pluripotent stem cells (hPSC) can be differentiated in vitro into various cell types, 31 providing both a model for basic research studies and a source of clinically relevant cells 32 (Vo and Daley, 2015) . During development, two waves of restricted hematopoietic 33 progenitors arise in the extraembryonic tissues of the yolk sac, before hematopoietic stem 34 cells (HSCs) emerge in the embryo proper (Palis, 2016) . The first "primitive" wave, gives 35 rise to erythrocytes, megakaryocytes and macrophages from embryonic day E7.25 in the 36 mouse embryo (Palis et al., 1999; Tober et al., 2007) . From E8.25, the first "definitive" 37 progenitors, called erythro-myeloid progenitors (EMPs) constitute the second wave and 38 these can be distinguished from the primitive progenitors by their potential to generate 39 granulocytes (McGrath et al., 2015) . Intraembryonic haematopoiesis is established during 40 E10.5-E11.5 by the emergence of HSCs, the only cells that can sustain the lifespan 41 production of all blood lineages, and maintain this property upon transplantation 42 (Medvinsky and Dzierzak, 1996) . 43
Despite many laboratories successfully recapitulating the development of multilineage 44 hematopoietic progenitors from hPSCs in vitro, the robust derivation of bona fide long-term 45
repopulating hematopoietic stem cells (HSCs) has not been achieved (Ditadi, Sturgeon 46 and Keller, 2017). Two main strategies have been employed in attempts to overcome this 47 challenge: modification of culture conditions to mimic embryonic ontogeny and the 48 overexpression of transcription factors in genetic programming experiments (Ivanovs et al., 49 2017) . Because the ontogeny of the human hematopoietic system is poorly characterised, 50 reproduction of the natural molecular cues occurring in the embryo is arduous. 51
Furthermore, the broad overexpression of target genes identified by bulk approaches has 52 failed to precisely reproduce the transcriptome of HSCs. In addition, the dynamic nature 53 and the heterogeneity of the hematopoietic progenitor cell populations that arise during 54 development poses additional confounders to the identification of both signalling and 55 target genes. To overcome these limitations, we propose that the in-depth characterisation 56 of hPSC-derived hematopoietic progenitors at the single cell level, and the subsequent 57 comparison with data sets obtained from haematopoietic progenitors generated in vivo, will 58 be instrumental for the development of new and improved strategies for their in vitro 59 production. Some single cell expression profiles of hPSC derived hematopoietic cells have 60 been reported to date, but they either used biased approaches such as preselected 61 probes (Guibentif et al., 2017) , or used a limited number of cells sorted with multiple 62 markers, thus impacting the heterogeneity resolution and the detection of subpopulations 63 (Angelos et al., 2018) . 64
Combining the use of two reporter cell lines and functional assays we designed a minimal 65 membrane marker strategy that allows the isolation of a broad, heterogeneous population 66
Single cell RNAseq of iPSCs-derived haematopoietic progenitor cells reveals the 133
transcriptome of naïve and lineage primed progenitors. 134
135
We collected exclusively suspension cells from two independent replicate cultures at day 136 13 of differentiation, isolated the CD235a -CD43 + cells containing the definitive 137 haematopoietic progenitors and subjected them to microfluidic single cell RNA libraries 138 preparation followed by sequencing and data analyses (Figure 2A ). After quality controls 139
and filtering of the data we obtained the transcriptome of 11420 cells (Supplementary 140 Figure S1A -E). Following dimensionality reduction through Principal Component Analysis 141 (PCA), we used graph-based clustering analysis and obtained 9 clusters of cells (Butler et 142 al., 2018a) and visualised on the tSNE projection ( Figure 2B ). Although the two replicates 143 did not show obvious differences (Supplementary Figure S2E) , we regressed out the batch 144 effect before pulling the samples together for further analysed. We assigned cell identities 145 based on the expression of known markers and identified markers from the dataset that 
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To study the hierarchical relationship between cell populations we performed trajectory 160 analysis using two different methods: diffusion analysis (Haghverdi et al., 2016) using the 161 Seurat R package (Butler et al., 2018b) and pseudotemporal ordering, using the Monocle 162 R package (Qiu et al., 2017) (Figure 3A-D) . Diffusion analysis identified a central core from 163 which three distinct trajectories appeared to emerge. The central core corresponded to 164 cells belonging to the progenitor clusters that we had annotated as naïve 1 and naïve 2 165 ( Figure 3A-B) . Branches comprised cells that expressed genes associated with specific 166
lineages, that we annotated as Ery-, Mega-and Granulo-priming directions. These three 167 lineages are expected to branch from EMPs, progenitors of the second wave of yolk sac 168 haematopoiesis (McGrath et al., 2015) . Comparable trajectories were observed using 169 pseudotemporal ordering. After calculating a pseudotime value for each cell, we ordered 170 them starting from a root state corresponding to the branch containing cells that were 171 located at the core of the diffusion plot and that we had identified as naïve progenitors in 172 our original clustering ( Figure 3C 
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To functionally validate the results of our trajectory analyses, we assessed the 189 haematopoietic potential of cells that we had defined as naïve progenitor populations. We 190 filtered the list of marker genes encoding membrane proteins and designed a prospective 191 sorting strategy to isolate the progenitor populations. Genes encoding the cell surface 192 markers CD33, CD44, and ITGB2 (also known as CD18) were enriched within clusters 193 associated with the naïve progenitors and so we hypothesised that these markers could 194 be used for their isolation (Supplementary Figure 3) . CD33 was expressed uniformly by 195 both naïve 1 and naïve 2 populations whereas CD44 and CD18 expression appeared 196 higher in the naïve 1 population (Supplementary Figure 3) . We used CD44 and CD18 to 197 fractionate the CD235a -CD43 + CD33 + cell population and identified the naïve 1A Figure 3B ). We compared the CFU-C capacity of naïve 1 and 2 progenitors that were 219 present at the different stages of the differentiation protocol. When plated in clonogenic 220 methylcellulose assays, only cells expressing CD44 on their membranes, naïve 1 cells 221 isolated from day 10 and 13, formed CFU-C colonies, whereas virtually no colonies were 222 generated by naïve 2 cells ( Figure 4D -E). These data indicate that CD44 membrane 223 expression alone resolves CFU-C forming cells and supports the hierarchy predicted by 224 the trajectory analyses ( Figure 3A-D) . Our results demonstrate that our chimeric co-culture 225 system is able to assess the lineage output that cannot be assessed by methylcellulose 226 assays alone. To assess whether the naïve cell populations identified using our unique 227 sorting strategy showed features of definitive haematopoietic progenitors, we assessed 228 the expression of the RUNX1C-GFP reporter in these cells. We observed RUNX1C-GFP 229 expression in both cell types, with a higher proportion of RUNX1C + cells in the naïve 1 230 compared to naïve 2 population (Supplementary Figure 3C) . We then focused our8 attention on the other transcription factors expressed by the progenitor clusters and 232 identified high levels of ID2 and ID4 in naïve progenitors ( Figure 3E ), with ID2 highly 233 expressed in naïve 1. ID genes are targets of BMP signalling, so we predicted that naïve 234 populations could be modulated by addition of BMPs. To test this hypothesis, we included 235 BMP4 in the differentiation culture from day 10, when both naïve 1 and 2 were present and 236 then assessed the proportion of these cells by day 13. The frequency of both naïve 1 and 237 2 cells increased by 25% and 59% respectively in the presence of BMP4 indicating that 238 this signalling pathway was involved in their expansion ( Figure 4F) . Table 1) . We observed that the cell surface markers such as 296 ICAM2 and CD9 seemed to be highly expressed later in their differentiation, in cluster 297 Mega-primed 3 ( Figure 6C) . We confirmed the co-expression of these markers by flow 298 cytometry and observed a population of CD41 + CD9 + ICAM2 + cells, with around 85% of the 299 CD41 + cells also expressing CD42a ( Figure 6D ). When CD41 + CD42 + cells were sorted 300 (Figure 6E ), no polyploidy was detected supporting their immature stage ( Figure 6F-301 Supplementary figure 4B) . 302
In
an EMP-like progenitor. We analysed the nuclear morphology of sorted CD235a -310 CD43 + CD18 + CD33 + CD44 -cells by microscopy. As expected, we detected the existence of 311 granulocytes and monocytes (and by inference, EMPs) by morphology ( Figure 6G ). To 312 resolve this heterogeneity, we sub-clustered the data and identified three putative cell 313 populations whose identity could be inferred by marker gene expression ( Figure 6H-L) . 314
One of these sub-clusters co-expressed genes associated with the naïve unprimed 315 progenitors (LMO4, GATA2 and FST) as well as genes associated with the eosinophil 316 lineage such as EPX, eosinophil peroxidase, and the proteoglycans PRG2 and PRG3 317 (Soragni et al., 2015) , and we speculate that these have a pro-eosinophil identity ( Figure  318 6I-L). Another cluster appeared to express high levels of neutrophil-associated genes such 319 as MPO, AZU1, PRTN3, LYZ, S100A8 and S100A9 and was thus annotated as a Pro-320
Neutrophil cluster (Figure 6I-L) . Finally, we typed the third cluster as monocytes due to the 321 expression of monocyte associated signature such as CSF1R, CXC3R1, and IRF8 ( Figure  322 6I-L). Noteworthy, RUNX3 expression was specifically associated with the monocyte 323 subcluster ( Figure 6I Cut colonies were transferred to a bacteriological grade well to form embryoid bodies and 444 cultured for two days. At day 2 media was changed and supplemented with 3 µM CHIR 445 (StemMacs). At day 3, embryoid bodies were collected and dissociated in Accutase 446 (Gibco) to single cell solution, cells were plated on tissue culture grade wells in SFD 447 medium supplemented with 5 ng/ml bFGF and 15 ng/ml VEGF (2x10 5 cells/well on 6 well 448 plates or 1x10 5 cells/well on 12 well plate). At day 6 media was changed for final 449 hematopoietic induction in SFD medium supplemented with 5 ng/ml bFGF, 15 ng/ml 450 VEGF, 30 ng/ml IL3, 10 ng/ml IL6, 5 ng/ml IL11, 50 ng/ml SCF, 2 U/ml EPO, 30 ng/ml 451 TPO, 10 ng/ml FLT3L and 25 ng/ml IGF1. From day 6 onward, cytokines were replaced 452 every two days. For further erythroid differentiation, SFD2 was used (IMDM, 10% HAS, 10 453 ng/ml insulin (Sigma-Aldrich), 200µ/ml Human Holo-Transferrin and Glutamax). At day 13, 454 3 x 10 5 cells were replated in SFD2 supplemented with 50 ng/ml SCF, 16.7 ng/ml FLT3L, 455 6.7 ng/ml BMP4, 6.7 ng/ml IL3, 6.7 ng/ml IL11, 3U/ml EPO, 50 µM IBMX and 10 µM 456
Hydrocortisone. At day 20, 10 6 cells were replated in SFD2 supplemented with 3U/ml 457 EPO, 6.7 ng/ml IL3, 6.7 ng/ml IL11, 20 ng/ml SCF and IGF1 20 ng/ml. From day 27 to day 458 30, 10 6 cells were terminally differentiation in SFD2 medium with 3U/ml EPO. human AB + serum, 3 U/ml heparin and 10 mg/ml Insulin) supplemented with 60 ng/ml 482 SCF, 5 ng/ml IL3, 3 U/ml EPO, 1mM Hydrocortisone and 200 mg/ml human holo-483
Transferrin. At day 6, batches were frozen for further use at 10 6 cells/ml in 60% ISHIT 484 media, 30% knockout serum replacement (Gibco) and 10% DMSO. Cells where thawed 485 and cultured for additional 2 days in the same medium. At day 8, cell density was adjusted 486 to 10 5 cells /ml in ISHIT media supplemented with 10 ng/ml SCF, 3 U/ml EPO, 300 mg/ml 487 and human holo-Transferrin, and cultured for a further 3 days. Finally, cells were cultured 488 at a density of 10 6 cells/ml in ISHIT medium supplemented with 3U/ml EPO and 300 mg/ml 489 human holo-transferrin until day 21. Media was changed every 3-4 days throughout the 490
protocol. 491 492
Flow cytometry staining and cell sorting. 493 From hematopoietic differentiation, suspensions cells were collected from the well by 494 aspiration of the media, adherent cells were detached from the well by using Cell 495 Dissociation Buffer (ThermoFisher). Cells were washed with PBS + 1% BSA, counted and 496 were stained at 10 5 cells for a single tube. Cells were stained with antibodies in 497 supplementary table X, for 30' at RT gently shaking. Flow cytometry data were collected 498 using DIVA software (BD). Sorting was performed using FACSAria Fusion (BD) and cells 499 were collected in PBS + 1%BSA. Data were analysed using FlowJo version 10. 4 
.2. 500
Yolk sacs and AGM from mouse embryos were micro dissected in PBS supplemented 2% 501 FBS and washed twice before tissue digest. Single cell suspensions were obtained by 502 incubation in 0.125% collagenase at 37°C for 45' for AGMs and 60' for yolk sacs, followed 503 by mechanical dissociation by pipetting and a final wash. 504
505

Antibody panels 506
The following antibodies were used for multicolour panels. Two independent sample of hiPSC SFCi55 were differentiated synchronously and sorted 533 at day 13 using CD235a -CD43 + immunophenotype, viable cells were sorted using DAPI. 534
Cell viability was also confirmed by Trypan blue stain for accurate count using TC20 cell 535 counter (Biorad). Around 12000 cells per sample were loaded into the 10X Chromium 536
Controller and single cell libraries were obtained using the Chromium single cell 3' 537 Reagent Kits v2 (10XGenomics) according to manufacturer protocol. RNA concentration 538 was obtained using Quibit RNA HS (Thermo-Fisher). Quality of the obtained libraries were 539 verified using LabChip GX (PerkinElmer). Libraries were sequenced using HiSeq 4000 540 technology (Illumina) at 50000 reads/cell. Data were aligned to GRCh38 using the Cell 541
Ranger dedicated pipeline (10XGenomics). Data filtering, dimension reduction, clustering 542 analysis and differentially expressed genes were obtained using Seurat.R package, cell 543 trajectories was obtained using Monocle.R (code and data are available on request 544 through corresponding authors). 545
546
Mouse embryo and yolk sac embedding and sectioning 547
Whole embryos with the yolk sac were fixed in 4% PFA overnight at 4°C on a gentle 548 shaker, yolk sac was detached from the embryo after fixation and processed in parallel to 549 the embryo. After rinsing them twice with PBS, they were placed in a solution of 15% 550 sucrose/PBS for 3h at 4°C and then transferred into PBS with 15% sucrose and 7% 551 gelatine at 37°C for 1-3h until they sank. Embryos and yolk sacs were mounted in gelatin 552 using mounting specimens (Sigma-Aldrich), snap-frozen in liquid nitrogen and stored at -553 80°C. 7μm-thick sections were cut using Cryotome FSE (Thermo ScientifiC) and further 554 processed for immunostaining or stored at -20°C 555 556
Immunostaining and microscopy 557
Gelatin was removed boiling the slide for 30" in PBS and washed twice in PBS, 558 permeabilized and blocked with 5% donkey serum + 0.3% triton-X100/PBS and stained 559 with primary antibodies overnight at 4°C (CD44: Stratech KM201, 1:100; LMO4: Thermo-560
Fisher PA5-24248, 1:200). Following three washes in PBS, sections were stainied with 561 secondary antibodies in 0.3% triton-X100/PBS for 2 hours at room temperature (anti-rat 562 Alexa Fluor 568, Thermo Fisher A-11077, 1:500, anti-rabbit Alexa Fluor 488, Thermo 563
Fisher A-11008, 1:500). After three washes in PBS, slides were counterstaining in 10 564 mg/ml DAPI. Samples were mounted with ProLong Gold Antifade mountant (Life 565 Technologies) and dried at room temperature in the dark for a minimum of 2h, then stored 566 at 4°C. Images were acquired using an inverted confocal microscope (Leica SP8) and 567 analyzed using ImageJ 1.50i (https://imagej.nih.gov/ij). 
